Detalhe da pesquisa
1.
Consent document translation expense hinders inclusive clinical trial enrolment.
Nature
; 620(7975): 855-862, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37532930
2.
Comprehensive tissue deconvolution of cell-free DNA by deep learning for disease diagnosis and monitoring.
Proc Natl Acad Sci U S A
; 120(28): e2305236120, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37399400
3.
Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples.
Breast Cancer Res Treat
; 148(2): 315-25, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25338319
4.
Targeting more precisely: Improving sensitivity to EGFR inhibitors in NSCLC.
Med
; 2(11): 1201-1202, 2021 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35590196
5.
Effectiveness of Single-Fraction, Low-Dose, Bilateral Whole Lung Radiation Therapy for Diffuse Alveolar Hemorrhage Secondary to Extramedullary Hematopoiesis: A Case Report and Review of the Literature.
Adv Radiat Oncol
; 9(7): 101506, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38799111
6.
Gender and disease-inclusive nomenclature consolidation of theragnostic target, prostate-specific membrane antigen (PSMA) to folate hydrolase-1 (FOLH1).
Front Med (Lausanne)
; 10: 1304718, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38444631
7.
Pembrolizumab in advanced non-small cell lung cancer: safety implications of dose adjustments.
Transl Cancer Res
; 11(12): 4479-4481, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36644181
8.
EMT is associated with, but does not drive resistance to ALK inhibitors among EML4-ALK non-small cell lung cancer.
Mol Oncol
; 10(4): 601-9, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26639656
9.
Three Primary Tumors Including EGFR-mutated Non-Small Cell Lung Cancer as First Presentation in Patient With Li-Fraumeni Syndrome.
Clin Lung Cancer
; 22(1): e116-e121, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33172777
10.
CRKL mediates EML4-ALK signaling and is a potential therapeutic target for ALK-rearranged lung adenocarcinoma.
Oncotarget
; 7(20): 29199-210, 2016 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-27078848
11.
Novel ALK Fusion, PPFIBP1-ALK, in Pancreatic Ductal Adenocarcinoma Responsive to Alectinib and Lorlatinib.
JCO Precis Oncol
; 42020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923899
12.
Oncogenic drivers, targeted therapies, and acquired resistance in non-small-cell lung cancer.
J Mol Med (Berl)
; 92(7): 697-707, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24852181